Rubella Screening and Immunization: Its History and Future-an Ongoing Challenge

Overview

Journal Can Fam Physician

Specialties General Medicine
Public Health

Date 2011 Jan 27

PMID 21267342

Authors

T M Gerace

Affiliations

Soon will be listed here.

Abstract

The Congenital Rubella Syndrome (CRS) continues to be a serious threat to the unborn child, since a significant number of women of childbearing age are susceptible to rubella. Vaccines and immunization programs, since their inception, have given us a false sense of security in our assumption that they have provided adequate protection. The ultimate purpose of immunization is the eradication of CRS; but to achieve this, an understanding of the evolution of vaccines and immunization programs is essential, in order to provide appropriate immunization today.This paper provides a review of rubella vaccines; immunization programs; current recommendations for screening and immunization; and the report of a five-year surveillance study of women of childbearing age, which found 17% of the subjects to be susceptible to rubella.

References

Horstmann D . Controlling rubella: problems and perspectives. Ann Intern Med. 1975; 83(3):412-7. DOI: 10.7326/0003-4819-83-3-412. View

Coulombe L, Rosser W . Can we prevent an increase in the incidence of congenital rubella syndrome in the next decade?. Can Med Assoc J. 1981; 125(1):37-40. PMC: 1862589. View

OShea S, Best J, Banatvala J, Marshall W, DUDGEON J . Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed). 1982; 285(6337):253-5. PMC: 1499591. DOI: 10.1136/bmj.285.6337.253. View

Chappell J, Taylor M . Implications of rubella susceptibility in young adults. Am J Public Health. 1979; 69(3):279-81. PMC: 1619093. DOI: 10.2105/ajph.69.3.279. View

Howard J, Kahn A . Rubella immunization policies for health care personnel. J Fam Pract. 1983; 17(5):805-7. View

Rossier E, PHIPPS P, POLLEY J, Webb T . Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination. Can Med Assoc J. 1977; 116(5):481-4. PMC: 1879342. View

Joncas J . Preventing the congenital rubella syndrome by vaccinating women at risk. Can Med Assoc J. 1983; 129(2):110-2. PMC: 1875261. View

Siegel M . Unresolved issues in the first five years of the rubella immunization program. Am J Obstet Gynecol. 1976; 124(4):327-32. DOI: 10.1016/0002-9378(76)90088-0. View

Schoenbaum S, Hyde JN Jr Bartoshesky L, Crampton K . Benefit-cost analysis of rubella vaccination policy. N Engl J Med. 1976; 294(6):306-10. DOI: 10.1056/NEJM197602052940604. View

10.

Welch J . Prevention of congenital rubella. Can Med Assoc J. 1977; 117(2):151-6. PMC: 1879698. View

11.

Middleton P, Larke R, Lessard P, Doran T . Guide to the management of rubella problems. Can Med Assoc J. 1977; 116(5):484-8. PMC: 1879346. View

12.

Mountifield J . An evaluation of immunization against rubella. Prim Care. 1978; 5(4):717-23. View

13.

Spika J, Clogg D . Rubella vaccination: a course becomes clear. Can Med Assoc J. 1983; 129(2):106-7, 110. PMC: 1875246. View

14.

Balfour Jr H, Groth K, Edelman C, Amren D, Best J, Banatvala J . Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet. 1981; 1(8229):1078-80. DOI: 10.1016/s0140-6736(81)92243-1. View

15.

Bolognese R, Corson S . Rubella vaccination. A critical review. Obstet Gynecol. 1973; 42(6):851-5. View

16.

Preblud S . Some current issues relating to rubella vaccine. JAMA. 1985; 254(2):253-6. View

17.

McKusick M . Community medicine: screening for rubella on a university campus. Postgrad Med. 1976; 59(3):200, 202, 204-5. DOI: 10.1080/00325481.1976.11714310. View

18.

Herrmann K, Halstead S, WIEBENGA N . Rubella antibody persistence after immunization. JAMA. 1982; 247(2):193-6. View

19.

Acres S, Varughese P . Impact of vaccination on selected diseases in Canada. Can Med Assoc J. 1985; 132(6):635-9. PMC: 1345782. View